PDC autoantibodies, such as those targeting the E1β subunit, are seen in 40-50% of PBC-SSc overlap cases [17,80], and E1α subunit antibodies in 15-20% of SSc cases, associated with PBC development [81]. This evidence concerns the gene PDC and systemic sclerosis.